TXG – 10x genomics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

TXG

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/12

09:26 am

txg

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]

Medium Report

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease [Yahoo! Finance]

Report

1/12

09:11 am

txg

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Medium Report

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Report

1/12

09:10 am

txg

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Medium Report

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Report

1/12

09:00 am

txg

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Medium Report

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Report

1/12

08:42 am

txg

10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.

Medium Report

10x Genomics (NASDAQ:TXG) was given a new $21.00 price target on by analysts at Needham & Company LLC.

Report

1/11

12:00 pm

txg

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Medium Report

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Report

1/7

01:18 pm

txg

10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.

Low Report

10x Genomics (NASDAQ:TXG) had its price target raised by analysts at TD Cowen from $15.00 to $18.00. They now have a "hold" rating on the stock.

Report

1/7

10:58 am

txg

10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.

Low Report

10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at Cowen Inc.

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/6/2025

04:05 pm

txg

10x genomics, inc.

BEAT Report

17.3%

10x genomics, inc.

Report

8/7/2025

04:05 pm

txg

10x genomics, inc.

BEAT Report

-4.0%

10x genomics, inc.

Report

5/8/2025

04:05 pm

txg

10x genomics, inc.

BEAT Report

1.0%

10x genomics, inc.

Report

2/12/2025

04:05 pm

txg

10x genomics, inc.

MISS Report

-2.5%

10x genomics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

12/22

08:00 am

Maintains

Buy

Canaccord Genuity

Medium

Report

4.2%

Report

12/15

03:52 pm

Maintains

Overweight

Barclays

Low

Report

0.0%

Report

12/15

03:52 pm

Maintains

Overweight

Barclays

Low

Report

0.0%

Report

12/15

07:02 am

Reiterates

Overweight

Barclays PLC

Low

Report

1.7%

Report

12/11

04:08 pm

Downgrades

Buy

Cautious

Citigroup Inc.

Medium

Report

-7.4%

Report

12/11

03:54 pm

Downgrades

Buy

Neutral

Citigroup

Low

Report

0.2%

Report

12/11

03:54 pm

Downgrades

Buy

Neutral

Citigroup

Low

Report

0.2%

Report

12/11

09:09 am

Downgrades

BUY

NEUTRAL

CITI

Medium

Report

-3.3%

Report

Date

Time

Symbol

Headline

Impact

1/12

03:53 pm

txg

Form 8-K 10x Genomics, Inc. For: Jan 11

Low Report

Form 8-K 10x Genomics, Inc. For: Jan 11

Report

1/8

09:28 am

txg

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC

Medium Report

Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC

Report

1/7

04:53 pm

txg

Form 4 10x Genomics, Inc. For: Jan 05 Filed by: Saxonov Serge

Medium Report

Form 4 10x Genomics, Inc. For: Jan 05 Filed by: Saxonov Serge

Report

11/25

05:25 pm

txg

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Taich Adam

Low Report

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Taich Adam

Report

11/25

05:24 pm

txg

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Hindson Benjamin J.

Low Report

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Hindson Benjamin J.

Report

11/25

05:23 pm

txg

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Saxonov Serge

Low Report

Form 4 10x Genomics, Inc. For: Nov 24 Filed by: Saxonov Serge

Report

11/24

05:33 pm

txg

Form 144 10x Genomics, Inc. Filed by: Hindson Benjamin J.

Medium Report

Form 144 10x Genomics, Inc. Filed by: Hindson Benjamin J.

Report

11/24

04:56 pm

txg

Form 144 10x Genomics, Inc. Filed by: Saxonov Serge

Medium Report

Form 144 10x Genomics, Inc. Filed by: Saxonov Serge

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.